Hospital-acquired infections (HAIs) remain one of the most persistent and costly challenges in healthcare today, impacting approximately 1 in 31 hospital patients on any given day in the U.S., according to the CDC. In this episode, Kismet Technologies’ CEO Shari Costantini sits down with Microbiology Manager Kelly Ager to explore the science and results behind NanoRAD, a breakthrough surface treatment designed for continuous protection. Drawing from a recent hospital study, Kelly shares the r...
All content for Kismet Tech Talks is the property of Kismet Technologies and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Hospital-acquired infections (HAIs) remain one of the most persistent and costly challenges in healthcare today, impacting approximately 1 in 31 hospital patients on any given day in the U.S., according to the CDC. In this episode, Kismet Technologies’ CEO Shari Costantini sits down with Microbiology Manager Kelly Ager to explore the science and results behind NanoRAD, a breakthrough surface treatment designed for continuous protection. Drawing from a recent hospital study, Kelly shares the r...
🧼 “The hospital is no place for a sick person.” In this clip, our CEO Shari Costantini sheds light on a painful truth: healthcare-associated infections (HAIs) continue to jeopardize patient outcomes in hospitals and care facilities across the country. At Kismet Technologies, we believe antimicrobial innovation should start where patients are most vulnerable. Our technology provides residual protection for both hard and soft surfaces, Because when someone walks into a hospital to g...
Kismet Tech Talks
Hospital-acquired infections (HAIs) remain one of the most persistent and costly challenges in healthcare today, impacting approximately 1 in 31 hospital patients on any given day in the U.S., according to the CDC. In this episode, Kismet Technologies’ CEO Shari Costantini sits down with Microbiology Manager Kelly Ager to explore the science and results behind NanoRAD, a breakthrough surface treatment designed for continuous protection. Drawing from a recent hospital study, Kelly shares the r...
